Gene editing can be used to treat blood disorders, fight cancer, grow more nutritious crops, detect infectious diseases, control mosquito populations, and even attempt to bring back extinct species. The technology, most commonly associated with CRISPR, has moved rapidly from laboratory experiments to real-world applications, with the first approved therapies now available to patients. Here’s a practical look at the major areas where gene editing is making a difference.
Treating Genetic Blood Disorders
The most visible success so far is in sickle cell disease. In 2023, the FDA approved Casgevy, the first CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. The treatment works by editing a gene called BCL11A in a patient’s own blood stem cells. Normally, BCL11A acts as a switch that shuts off production of fetal hemoglobin after birth. By disabling that switch, edited stem cells start producing fetal hemoglobin again, which compensates for the defective adult hemoglobin that causes sickle cell crises.
The practical result for patients: fewer painful vaso-occlusive episodes and, in clinical trials, elimination of the need for regular blood transfusions. The process involves collecting a patient’s stem cells, editing them in a lab, then infusing them back after chemotherapy clears the bone marrow. It’s a demanding treatment, but for a disease that causes lifelong pain and organ damage, the outcome is significant.
Engineering Immune Cells to Fight Cancer
CAR-T cell therapy, where a patient’s immune cells are reprogrammed to hunt cancer, has already shown remarkable results against blood cancers like leukemia and lymphoma. Gene editing is now being used to make these therapies more effective. The core problem is that CAR-T cells often become exhausted or dysfunctional inside the body, leading to treatment failure.
Researchers are using CRISPR to knock out specific genes that contribute to this exhaustion. A 2025 study published in Nature identified several gene knockouts, including genes called RHOG, PRDM1, and FAS, that boosted CAR-T cell performance in animal models of human leukemia. The goal is to produce immune cells that stay active longer and kill cancer cells more aggressively. These approaches are still in the research phase for most cancers, but they represent one of the most active areas of gene editing development.
Growing More Nutritious, Resilient Crops
Agriculture may be where gene editing eventually touches the most people. CRISPR is being used to edit staple crops like rice, wheat, and soybeans in ways that were previously slow or impossible through traditional breeding.
Some of the most promising work targets nutrition. In rice and wheat, genes have been edited to increase iron and zinc levels, directly addressing micronutrient deficiencies that cause anemia and weakened immune function in millions of people worldwide. In rice specifically, editing a gene called OsBADH2 increases production of a compound that gives the grain a desirable fragrance, making nutritious varieties more appealing to consumers.
Disease resistance is another major focus. Powdery mildew, a fungal infection that damages soybean and wheat harvests, can be reduced by knocking out susceptibility genes that the fungus exploits to infect the plant. In rice, editing a single gene has conferred resistance to root-knot nematode, a pest responsible for significant yield losses. These edits don’t introduce DNA from other species. They make precise changes to the plant’s own genome, which has simplified regulatory approval in some countries compared to traditional GMOs.
Rapid Disease Diagnostics
Gene editing tools aren’t just for changing DNA. They can also be used to detect it. CRISPR-based diagnostic platforms like SHERLOCK and DETECTR repurpose the system’s ability to find specific genetic sequences, turning it into a fast, portable pathogen detector.
These diagnostics are impressively accurate. CRISPR-Cas13 assays achieve greater than 95% sensitivity and greater than 99% specificity across multiple pathogens. In testing for SARS-CoV-2 during the pandemic, SHERLOCK demonstrated 100% sensitivity and 96% specificity when working directly with patient samples. For Zika virus detection using purified RNA, it hit 100% on both measures.
The practical advantage over traditional lab tests is speed and simplicity. These assays can potentially be run outside a hospital lab, making them useful for outbreak response in remote areas or for rapid screening at points of care. They don’t require the expensive thermal cycling equipment that standard PCR tests depend on.
Controlling Malaria-Carrying Mosquitoes
Gene drives are one of the most ambitious applications of gene editing. The idea is to engineer mosquitoes with genetic modifications that spread through wild populations far faster than normal inheritance would allow. In standard genetics, a modified gene has a 50% chance of passing to offspring. A gene drive pushes that probability much higher, allowing an engineered trait to sweep through a population over just a few generations.
Two strategies are under development for malaria control. The first modifies mosquitoes so they can no longer transmit the Plasmodium parasite that causes malaria, essentially making them harmless carriers. The second is population suppression: engineering mosquitoes with traits that reduce fertility or skew sex ratios toward males, causing the population to crash in a targeted region. Both approaches are still in contained laboratory and cage trials, and the ecological and ethical questions around releasing self-spreading genetic modifications into the wild remain subjects of intense debate.
Treating Cystic Fibrosis and Rare Diseases
About 10% of cystic fibrosis patients carry a type of mutation (called a nonsense mutation) in the CFTR gene that current medications can’t address. Gene editing offers a potential path for these patients. Researchers have used CRISPR delivered via lipid nanoparticles, tiny fat-based capsules, to correct CFTR mutations directly in the lungs of mouse models. A technology called selective organ targeting (SORT) nanoparticles allows these editing tools to be directed specifically to lung tissue, which is critical since cystic fibrosis primarily damages the lungs.
This work is still preclinical, but it illustrates a broader trend. Gene editing is being explored for hundreds of rare genetic diseases where the underlying cause is a single known mutation. If the editing tools can be delivered safely to the right tissue, many conditions that currently have no effective treatment could become correctable at their genetic source.
Biofuel Production
Gene editing is also being applied to industrial challenges. Microalgae are a promising source of biofuel because they produce lipids (oils) that can be converted into fuel, but natural lipid yields are often too low to be commercially viable. CRISPR interference, a technique that dials down gene activity without permanently cutting DNA, has been used to reduce expression of a specific gene in the algae species Phaeodactylum tricornutum. The result was dramatic: edited strains produced between 7 and 20 times more lipids than unmodified algae. That kind of increase could eventually make algae-based biofuels competitive with fossil fuels.
De-Extinction and Conservation
Perhaps the most headline-grabbing use of gene editing is the attempt to bring back traits of extinct species. Colossal Biosciences is working to produce a cold-adapted elephant that resembles a woolly mammoth by comparing mammoth and Asian elephant genomes, then editing elephant cells to introduce mammoth traits like shaggy hair, long tusks, and large fat stores. As a proof of concept, the company created “woolly mice,” lab mice with gene edits that produce shaggier coats, demonstrating that the relevant genetic pathways can be activated through editing.
The scientific rationale goes beyond novelty. Mammoth-like elephants could theoretically help restore grassland ecosystems in the Arctic tundra, which some researchers believe would slow permafrost thaw. Whether the project succeeds, it demonstrates how far gene editing has expanded beyond medicine into ecology and conservation biology.